-
Cell Research: Single-cell chromatin accessibility sequencing technology based on a single molecule sequencing platform
Time of Update: 2022-10-20
On October 11, 2022, the Tang Fuyi research group of the Center for Biomedical Frontier Innovation (BIOPIC) of Peking University published a paper entitled scNanoATAC-seq: a long-read single-cell ATA
-
Single-cell chromatin accessibility sequencing technology based on single-molecule sequencing platform
Time of Update: 2022-10-20
On October 11, 2022, the Tang Fuyi research group of the Center for Biomedical Frontier Innovation (BIOPIC) of Peking University published a paper entitled scNanoATAC-seq: a long-read single-cell ATA
-
Front Immunol: A single-cell resolution study of chromatin accessibility in peripheral blood
Time of Update: 2022-04-16
PBMC, peripheral blood mononuclear cells; scATAC-seq, single-cell sequencing analysis of transposase-accessible chromatin; SLE_PBMC, systemic lupus erythematosus (SLE) patient PBMC; NC_PBMC, normal human PBMC; NK cells, natural killer cells; DC , dendritic cell; TF, transcription factor; TSS, transcription start site .
-
Domestic qutoju single anti-sea milestone: approved by the British NHS procurement, access to a number of top hospitals in Europe
Time of Update: 2020-12-20
Since Fuhong Hanxuan's independent development and production of Quto Zhudan anti-Hanquyou (HLX02, EU commodity name: Zercepac) in July-August this year in China and the European Union approved the si
-
of Anti-Tumor Innovative Drugs Registered in Single Arm Trials for Access to Key Pre-Trial Clinical Aspects
Time of Update: 2020-05-28
notice on the public request for opinions on the Technical Guidelines for Communication and Communication of Anti-Tumor Innovative Drugs registered in single-arm trials before entering key trials :
